Merrell is the division chief of neuro-oncology and associate professor of neurology at Vanderbilt University Medical Center.
May 25, 2025
Video
IDH inhibitors, now FDA approved for lower-grade gliomas, yield fewer side effects than chemotherapy, said Dr. Ryan Merrell.
Addressing Cancer Care Barriers with Compassion and Cost Savings
Should I Quit My Day Job While Living With Cancer?
How Q-TWiST Can Guide Kidney Cancer Treatment Choices
Metastasis-Directed Radiotherapy Shows Improved Kidney Cancer Outcomes